Active Ingredients: Amoxicillin
A few moments later I wiped the gel off my belly, it was warm by then and I sat up. What had just happened?
My body had failed me desperately and nobody knew the pain and grief we were both going through as a couple. In some ways, I wish I had been brave enough to talk about it sooner — I think it would have helped. A new job, pictures from a holiday or in some cases the inevitable pregnancy announcement.
The reality is, in life, things do go wrong but life very rarely stays still. Introduction Helicobacter pylori colonize in the stomach and cause various diseases such as peptic ulcers, gastric cancer, and gastric mucosa-associated lymphoid tissue MALT lymphoma.
Furthermore. Current clinical guidelines recommend a clarithromycin-containing standard triple therapy STT as the first-line treatment and a bismuth-containing quadruple therapy BCQT or levofloxacin-based therapy LBT as the second-line treatment after failure of the STT.
However, due to increasing clarithromycin resistance, the eradication rate using the STT has decreased and ranges from 61. For this reason, extensive research has been conducted to find alternative therapies such as sequential therapy, concomitant therapy, LBT, and rifabutin-based therapy to replace STT.
LBT has been mainly used as a rescue therapy because quinolone resistance is a concern.
However, LBT as a first-line therapy has remained controversial. In this study, we evaluate the efficacy and safety of ilaprazole 10 mg bid, levofloxacin 500 mg bid, and amoxicillin 1000 mg bid as a first-line treatment for H.
Materials and Methods 2. Study Population In this single-center prospective study, we included patients with gastric ulcer, duodenal ulcer including scar, and gastritis with confirmed H. Patients were recruited from the outpatient gastroenterology department in Daejeon St.
All participants agreed to take part in this clinical study and provided informed consent. Exclusion criteria included age under 20 years; allergy or hypersensitivity to the test drugs; pregnancy, breast feeding, childbearing age, and not using appropriate contraception; uncontrolled diabetes mellitus DM or hypertension HTN; drug or alcohol abuse; history of malignancy within the last 5 years excluding those who underwent endoscopic curative resection for gastric dysplasia or early gastric cancer; history of surgery such as esophagectomy or gastrectomy; hereditary diseases such as galactose intolerance, lactase deficiency, and glucose-galactose malabsorption; and current participation in another clinical trial.
We withdrew subjects who had critical adverse reactions that required hospitalization and laboratory abnormalities over 1.